MGMelody C. Guo

Melody C. Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melody C. Guo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Catalyst–Substrate Pairings for Carbocyclic and Heterocyclic Systems in Atroposelective Quinazolinone Synthesis

    by Melody C. Guo, Scott J. Miller

    Asymmetric catalytic reaction development depends critically on the matching of an appropriate catalytic scaffold with a substrate of interest. In many cases, a catalyst will be discovered to be quite selective for a given substrate, and that same catalyst is then evaluated for its scope with respect to alterations of the substrate. In the context of a catalytic atroposelective cyclocondensation, we discovered that a chiral phosphoric acid catalyst (CPA), (R)-TCYP, mediated these processes with up to 98:2 enantiomeric ratio (er) and in 95% yield. Yet, when the same reaction was attempted in the presence of a basic nitrogen heteroatom within the substrate, enantioselectivity was significantly reduced (73:27 er). In these instances, a different catalyst scaffold based on phosphothreonine (pThr), while ineffective for the carbocyclic substrate (53:47 er), was found to be quite selective (90:10 er) for its pyridyl analog. Mechanistic studies exploring this divergence in reactivity unveiled that the 8-carbocyclic substrate (using (R)-TCYP) displayed a positive nonlinear effect (NLE), whereas the 8-heterocyclic substrate (using a pThr-based catalyst) displayed no NLE at all. The mechanistic distinctions between these two scenarios suggest significant differences in the nature of the noncovalent interactions that operate to deliver high enantioselectivity.


  • Enantioselective Sulfonimidamide Acylation via a Cinchona Alkaloid-Catalyzed Desymmetrization: Scope, Data Science, and Mechanistic Investigation

    by Brittany C. Haas, Ngiap-Kie Lim, Janis Jermaks, Eden Gaster, Melody C. Guo, Thomas C. Malig, Jacob Werth, Haiming Zhang, F. Dean Toste, Francis Gosselin, et al.

    Methods to access chiral sulfur(VI) pharmacophores are of interest in medicinal and synthetic chemistry. We report the desymmetrization of unprotected sulfonimidamides via asymmetric acylation with a cinchona-phosphinate catalyst. The desired products are formed in excellent yield and enantioselectivity with no observed bis-acylation. A data-science-driven approach to substrate scope evaluation was coupled to high throughput experimentation (HTE) to facilitate statistical modeling in order to inform mechanistic studies. Reaction kinetics, catalyst structural studies, and density functional theory (DFT) transition state analysis elucidated the turnover-limiting step to be the collapse of the tetrahedral intermediate and provided key insights into the catalyst-substrate structure-activity relationships responsible for the origin of the enantioselectivity. This study offers a reliable method for accessing enantioenriched sulfonimidamides to propel their application as pharmacophores and serves as an example of the mechanistic insight that can be gleaned from integrating data science and traditional physical organic techniques.


  • Open Access

    Enantioselective Sulfonimidamide Acylation via a Cinchona Alkaloid-Catalyzed Desymmetrization: Scope, Data Science, and Mechanistic Investigation

    by Brittany Haas, Ngiap-Kie Lim, Janis Jermaks, Eden Gaster, Melody Guo, Thomas Malig, Jacob Werth, Haiming Zhang, F. Dean Toste, Francis Gosselin, et al.

    Methods to access chiral sulfur (VI) pharmacophores are of interest in medicinal and synthetic chemistry. We report the desymmetrization of unprotected sulfonimidamides via asymmetric acylation with a cinchona-phosphinate catalyst. The desired products are formed in excellent yield and enantioselectivity with no observed bis-acylation. A data science-driven approach to substrate scope evaluation was coupled to high throughput experimentation (HTE) to facilitate statistical modeling in order to inform mechanistic studies. Reaction kinetics, catalyst structural studies, and density functional theory (DFT) transition state analysis elucidated the turnover-limiting step to be the collapse of the tetrahedral intermediate and provided key insights into the catalyst-substrate structure-activity relationships responsible for the origin of enantioselectivity. This study offers a reliable method for accessing enantioenriched sulfonimidamides to propel their application as pharmacophores and serves as an example of the mechanistic insight that can be gleaned from integrating data science and traditional physical organic techniques.

  • Open Access

    High-throughput determination of enantiopurity in atroposelective synthesis of aryl triazoles

    by Jongdoo Lim, Melody Guo, Sooyun Choi, Scott J. Miller, Eric V. Anslyn

    A facile, cost and time saving circular dichroism (CD) based assay is developed for high-throughputeedetermination in atroposelective synthesis of aryl triazoles.


  • Catalytic Asymmetric Synthesis of Atropisomeric N-Aryl 1,2,4-Triazoles

    by Sooyun Choi, Melody C. Guo, Gavin M. Coombs, Scott J. Miller

    The atroposelective synthesis of N-aryl 1,2,4-triazoles was developed. A cyclodehydration reaction was rendered asymmetric with the use of a chiral phosphoric acid catalyst to afford atropisomeric N-aryl 1,2,4-triazoles in up to 91:9 er. Recrystallization of the isolated heterocycle further enriched the atropisomeric ratio of several analogs to 99:1 er or greater. A divergent and substrate-dependent reaction pathway yielding a different heterocyclic product is also disclosed.